Ashley Yocum, PhD, is the executive research strategy lead at the Leukemia & Lymphoma Society.
Yocum Discusses Updated Data From the Beat AML Master Trial
Ashley Yocum, PhD, discusses the Beat AML trial of biomarker-based treatments in acute myeloid leukemia.
